Table 2 Patient diagnostic characteristics by cured and not cured
All (n=96) | Cured (n=46) | Not cured (n=50) | P-value (cured vs. not cured) | |
|---|---|---|---|---|
ARR after captopril challenge test | 1977±2162 | 2127±1567 | 1831±2630 | 0.5565 |
PRA after furosemide upright test, ng ml−1 h−1 | 0.7±1.8 | 0.4±0.3 | 0.9±2.5 | 0.2063 |
PAC after saline loading test, pg ml−1 | 331±263 | 376±258 | 283±265 | 0.1853 |
AVS before ACTH stimulation | ||||
PACdominat, pg ml−1 | 13 385±16 907 | 13 784±18 225 | 13 031±15 844 | 0.839 |
LR | 21.7±26.5 | 24.7±28.5 | 18.9±24.5 | 0.3216 |
CR | 1.0±1.4 | 0.8±1.0 | 1.2±1.7 | 0.2216 |
AVS after ACTH stimulation | ||||
PACdominant, pg ml−1 | 69 503±68 686 | 77 697±79 009 | 61 689±57 009 | 0.2884 |
LR | 13.2 ±12.9 | 13.5±12.1 | 12.9±13.8 | 0.8576 |
CR | 0.5±0.5 | 0.4±0.2 | 0.7±0.6 | 0.0033 |
CS, n (%) | 72 (87) | 40 (97.6) | 32 (76.2) | 0.0041 |